Lupin Ltd, a pharmaceutical company launched generic Abacavir and Lamivudine tablets for HIV in the US. In a regulatory filing in BSE, the company said it has launched Abacavir and Lamivudine tablets 600 mg/300 mg after an approval from the United States Food and Drug Administration (USFDA) earlier.
‘Generic Abacavir and Lamivudine tablets for HIV have been AB Rated, i.e., equivalent to branded Epzicom tablets.
’
According to Lupin, Abacavir and Lamivudine tablets, 600 mg/300 mg are the AB rated generic equivalent of ViiV Healthcare Company's Epzicom tablets, 600 mg/300 mg. It is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Epzicom tablets had US sales of $388.1 million, said the company.
Source-IANS